Skip to content

Exploratory study for biomarkers in semen predicting the malignancy of prostate cancer

Exploratory study for biomarkers in semen predicting the malignancy of prostate cancer - Exploratory study for biomarkers in semen predicting the malignancy of prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035673
Enrollment
100
Registered
2019-11-30
Start date
2018-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

None listed

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients treated with Prostate biopsy or prostate cancer patients who undergo prostatectomy

Exclusion criteria

Exclusion criteria: Patients with cancer other than in the prostate

Design outcomes

Primary

MeasureTime frame
PROS1 in semen measured by ELISA method

Secondary

MeasureTime frame
LTBP1 and 8-OHdG in semen measured by ELISA method

Countries

Japan

Contacts

Public ContactShigeo Horie

Juntendo University, Graduate School of Medicine Department of Urology

shorie@juntendo.ac.jp03-5802-1227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026